Advancements in medical technologies, new procedures, diagnostic tests, and effective drugs continue apace. But like most things in life, there is an upside and a downside.
Consider the issue of early detection the dreaded Alzheimer’s disease. An article in Georgetown Magazine, fall edition, entitled “The Power to Predict Alzheimer’s Disease Before It Starts,” by Sara Piccini, offers points to ponder. While not yet a reality, Piccini notes that “current research underway at Georgetown [University] and other institutions may soon lead to the development of a predictive blood test for Alzheimer’s disease that is highly accurate, inexpensive, and easy to administer.”
Alzheimer’s disease, always fatal, afflicts one in nine Americans beyond age 65. Financial advisors increasingly are helping families cope with the financial and life transitional impact of the disease and the toll it takes on caregivers.
Families require special planning not just for end-of-life circumstances but the transition period. That goes for any affliction that calls for a period of caregiving before death. Forthright conversation among family members long before a crisis erupts is important to piece of mind.
Advancements in genetic testing are expanding medical tests that identify changes in chromosomes, genes, or proteins. According to the U.S. National Library of Medicine, over 1,000 genetic tests are in use, with more under development.
The results can confirm or rule out a suspected genetic condition or help determine a person’s chance of developing or passing on a genetic disorder. You might undergo a test to look for signs of a disease, if you think you have an elevated risk of an ailment in the future or suspect you might pass on one to children, or you are pregnant and want a test for an unborn child.
Picinni raises a very troubling question in her piece: If you could find out, would you really want to know? Ethical dilemmas arise, including issues surrounding self-administered or assisted suicide, abortion and the creation of “designer babies.”
A positive aspect is that knowing what is to come allows time to prepare personal, financial and family affairs for that day.
The Kiplinger Letter on Nov. 14 reported a number of medical advances. New drugs are coming to fight cancers, including melanoma and malignancies of the bladder, lungs and stomach. A new treatment for heart failure promises a higher survival rate than with current medications. New treatments for lung disease, universal flu vaccines, non-statin cholesterol controllers and cheaper and faster lab and blood tests are on the horizon. Some advances will save time and money, but others, including pricey drugs, will raise costs.
Individuals may see higher insurance premiums, deductibles, co-pays and exclusions. Employers with health plans will see higher costs, some or all of which get passed on to employees. If predictive diagnostic tests are available, could insurance companies demand them, thereby rejecting applications for long-term care or disability insurance, or other coverage?
People saving for retirement have to consider the possibility of living longer while incurring rising costs for long-term care or other forms of incapacity or dependence. Today with Medicare, a couple with fairly common medical challenges like diabetes, or arthritis can spend $12,000 to $15,000 per year on premiums, co-pays, deductibles, donut holes on drug coverage (temporary limits on plan-supplied medications, where you must pay out of pocket) and non-covered items such as hearing aids and dental care.
USA Today last April reported that health-care spending growth hit a 10-year high early in 2014. With the age wave rolling on, health expenditures must be a major consideration when it comes to the sustainability of cash flows from your investments in retirement.
Retirees, and relatives who may serve as caregivers, need to join the family care conversation. Have you made arrangements for powers of attorney for assets and health care, advance directives, insurance coverage? If you are the go-to adult child, do you know what your parents want? Mom and dad, are your children clear as to your wishes? Would they know how to help and how to access resources, including money?
In a Nov. 19, 1999, Tom Wilson Ziggy comic strip, the character mused, “I’ve finally reached the age where my Wild Oats have turned into All-Bran.” Yin and yang. At least All-Bran is cheaper than Wild Oats and potentially more healthy.
Follow AdviceIQ on Twitter at @adviceiq.
Lewis Walker, CFP, is president of Walker Capital Management, LCC in Peachtree Corners, Ga. Securities and certain advisory services offered through The Strategic Financial Alliance Inc. (SFA). Lewis Walker is a registered representative of The SFA, which is otherwise unaffiliated with Walker Capital Management. 770-441-2603. lewisw@theinvestmentcoach.com.
AdviceIQ delivers quality personal finance articles by both financial advisors and AdviceIQ editors. It ranks advisors in your area by specialty, including small businesses, doctors and clients of modest means, for example. Those with the biggest number of clients in a given specialty rank the highest. AdviceIQ also vets ranked advisors so only those with pristine regulatory histories can participate. AdviceIQ was launched Jan. 9, 2012, by veteran Wall Street executives, editors and technologists. Right now, investors may see many advisor rankings, although in some areas only a few are ranked. Check back often as thousands of advisors are undergoing AdviceIQ screening. New advisors appear in rankings daily.